⌘K

Login Start Free

Home/Filings/4/A/0001493152-23-040177

4/A//SEC Filing

Morris Gabriel S 4/A

Accession 0001493152-23-040177

CIK 0001873835other

View on SEC.gov Company Profile

Filed

Nov 8, 7:00 PM ET

Accepted

Nov 9, 7:57 PM ET

Size

5.3 KB

Accession

0001493152-23-040177

Insider Transaction Report

Form 4/AAmended

Period: 2023-08-14

Immix Biopharma, Inc.IMMX

Morris Gabriel S

DirectorCFO

Transactions

Award
Stock Options
2023-08-14+293,000→ 293,000 total
Exercise: $1.86Exp: 2033-08-14→ Common Stock (293,000 underlying)

Footnotes (1)

[F1]Options vest monthly over 48 months from the date of grant.

Documents

1 file

4
ownership.xml

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1

filerCIK 0001889967

Filing Metadata

Form type: 4/A
Filed: Nov 8, 7:00 PM ET
Accepted: Nov 9, 7:57 PM ET
Size: 5.3 KB

View on SEC.gov